Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
Vertex Pharmaceuticals(VRTX.US) Officer Sells US$1.08 Million in Common Stock
Wells Fargo Updated Its Signature Picks, With Vertex Pharma and AvalonBay as Adds
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Vertex Pharmaceuticals Initiated at Buy by Redburn Atlantic
Redburn Atlantic Initiates Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Announces Target Price $545
Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Gain Rotation Out of Semis Is Feeding Into Other Parts of the Market - Argus
Form 144 | Vertex Pharmaceuticals(VRTX.US) Officer Proposes to Sell 1.08 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 26, $Vertex Pharmaceuticals(VRTX.US)$ Officer Bozic Carmen intends to sell 2,280 shares of its common stock on Jun 26, with a total market value of approximately $1.08 mill
Express News | Vertex Pharmaceuticals Inc : Piper Sandler Raises Target Price to $500 From $456
Maxim Group Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating
Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
Vertex Pharmaceutical Incorporated. (VRTX): Analysts Are Bullish on This Healthcare Stock's Strong Financial Performance in Q1
BofA Securities Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550
Vertex Pharmaceuticals Is Maintained at Overweight by Wells Fargo
Vertex Pharmaceuticals Analyst Ratings